期刊文献+

右美托咪定对室间隔缺损修补术婴儿心肌损伤的影响 被引量:2

Effect of dexmedetomidine on myocardial injury in infants undergping repair of ventricular septal defect
原文传递
导出
摘要 目的评价右美托咪定对室间隔缺损修补术婴儿心肌损伤的影响。方法择期拟行室间隔缺损修补术婴儿40例,3—6月龄,体重4—6kg,ASA分级Ⅱ或Ⅲ级,采用随机数字表法,将其分为2组(n=20):对照组(C组)和右美托咪定组(D组)。人室后开放静脉通路,麻醉诱导后经鼻气管插管,行机械通气。D组在麻醉诱导后持续静脉输注右美托咪定0.5μg·kg^-1·h^-1至术毕,C组相同速率持续静脉输注生理盐水至术毕。于术前10min(T1)、切皮(T2)、胸骨劈开即刻(T3)、主动脉开放后10min(T4)和术毕(T5)时记录HR和BP。于T1、T5和术后24h(R)时采集右颈内静脉血样,测定血浆肌酸酶同工酶(CK.MB)活性和心肌肌钙蛋白T(cTnT)浓度。结果与L时比较,D组各时点HR和BP差异无统计学意义(P〉0.05),C组T3-5时HR和BP升高,2组T5-6时血浆CK-MB活性及cTnT浓度升高(P〈0.05)。与C组比较,D组T2-5时HR和BP、T5-6时血浆CK—MB活性及cTnT浓度降低(P〈0.05)。结论麻醉诱导后静脉输注右美托咪定0.5μg·kg^-1·h^-1可减轻室间隔缺损修补术婴儿的心肌损伤程度。 Objective To evaluate the effect of dexmedetomidine on myocardial injury in infants undergo- ing repair of ventrieular septal defect. Methods Forty ASA grade Ⅱ or Ⅲ infants, aged 3-6 months, weighing 4- 6 kg, scheduled for elective repair of ventricular septal defect, were randomly divided into 2 groups ( n = 20 each) : control group (group C) and dexmedetomidine group (group D). Anesthesia was induced with midazolam, etomidate, cisatracurium and sufenanil. The infants were mechanically ventilated after nasotracheal intubation. PET CO2 was maintained at 30-40 mm Hg, Anesthesia was maintained with cisatraeurium, sufenanil and sevoflurane. In group D, dexmedetomidine was infused at 0.5 μg·kg^-1·h^-1 until the end of operation. While in group C nor- mal saline was given at the same rate until the end of operation. BP and HR were recorded at 10 min before opera- tion (T1), skin incision (T2), chest opening (T3 ) , 10 min after aortic unclamping (T4) and the end of operation (T5 ) . Blood samples were taken from the right internal jugular vein for determination of plasma creatine kinase MB (CK-MB) activity and cardiac troponin T (cTnT) concentrations at Tl , T5 and 24 h after operation (T6) .Results Compared with the baseline value at T1 , no significant changes were found in HR and BP at different time points in group D, HR and BP were significantly increased at T2-T5 in group C, and the plasma CK-MB ctivity and cTnT concentration were significantly increased at T5 and Ts in the two groups ( P 〈 0.05). HR and BP at T2_5 and plas- ma CK-MB activity and cTnT concentration at T5 and T6 were significarttly lower in group D than in group C ( P 〈 0.05). Conclusion Dexmedetomidine infused at 0.5 μg·kg^-1·h^-1 after induction can reduce myocardial injuryin infants undergoing repair of ventricular septal defect.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2013年第3期325-327,共3页 Chinese Journal of Anesthesiology
关键词 右美托咪啶 室间隔缺损 婴儿 心肌再灌注损伤 Dexmedetomidine Heart septal defects, ventricular Infant Myocardial reperfusioninjury
  • 相关文献

参考文献7

二级参考文献25

  • 1[15]Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond),1995, 88:551-556.
  • 2[16]Jerberg T, Lindahl B, Siegbahn A, et al. N-terminal pro brain natriuretic peptide in relation to inflammation,myocardial necrosis and the effects of an invasive strategy in unstable coronary artery disease. J Am Coll Cardial, 2003, 42:1909-1916.
  • 3[17]Sato Y, Yamada T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation,2001,103:369-374.
  • 4[18]Horwich TB, Patel J, MacLellan RW, et al. Cardiac troponin Ⅰ is associated with impaired hemodynamics,progressive left ventricular dysfunction, and increased mortality in advanced heart failure. Circulation,2003,108: 833-838.
  • 5[19]Venge P, Lagerqvist B, Diderholm E, et al. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC Ⅱsubstudy). Am J Cardial, 2002,89:1035-1041.
  • 6[1]Panteghini M. Acute coronary syndrome. Biochemical strategies in the troponin era. Chest, 2002,122:1428-1435.
  • 7[2]Alpert JS, Thygesen K, Antman E,et al. Myocardial infarction redefined consensus document of the Joint European Society of Cardiology/Am college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol, 2002,36: 959-969.
  • 8[3]Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation, 1979,59: 607-608.
  • 9[4]Panteghini M.Role and importance of biochemical markers in clinical cardiology. European Heart Journal,2004, 25:1187-1196.
  • 10[5]Wu AHB. National academy of clinical biochemistry standards of laboratory practice: recommendations for the uso of cardiac markers in coronary artery diseases. Clin Chem, 1999,45: 1104-1121.

共引文献86

同被引文献13

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部